Exelixis reported $6.66B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.67B 1.24B
Acceleron Pharma XLRN:US $ 10.52B 2.9B
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Akebia Therapeutics AKBA:US $ 502.67M 104.17M
Amgen AMGN:US $ 120.75B 19.29B
AstraZeneca AZN:LN 138.77B 24.78B
Bayer BAYN:GR 46.18B 4.3B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Bristol Myers Squibb BMY:US $ 131.34B 17.15B
Cytokinetics CYTK:US $ 2.98B 1.57B
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Eisai 4523:JP 2489.98B 750.02B
Eli Lilly And LLY:US $ 221.02B 902.49M
Esperion Therapeutics ESPR:US $ 340.74M 255.52M
Exelixis EXEL:US $ 6.66B 950.22M
Genmab GEN:DC 184.51B 16.13B
Glaxosmithkline GSK:US 95.15B 3.61B
Immunogen IMGN:US $ 1.18B 139.17M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Macrogenics MGNX:US $ 1.28B 335.6M
Merk MRK:US $ 190131.55M 6786.63M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Moderna Inc MRNA:US $ 155.35B 61B
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Neurocrine Biosciences NBIX:US $ 9.08B 123.68M
Novartis NOVN:VX 187.04B 20.99B
Pfizer PFE:US $ 241143.67M 21937.97M
Puma Biotechnology PBYI:US $ 286.61M 83.91M
Sanofi SNY:US 121.56B 10.5B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Takeda 4502:JP 5852.75B 17.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Xencor XNCR:US $ 1.9B 103.31M
YTE INCY:US $ 15.19B 3.31B